Parallax Volatility Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.09M | Sell |
102,500
-8,600
| -8% | -$501K | 0.02% | 526 |
|
|
2025
Q4 | $5.99M | Buy |
111,100
+26,100
| +31% | +$1.26M | 0.01% | 624 |
|
|
2025
Q3 | $3.83M | Buy |
85,000
+55,000
| +183% | +$2.57M | 0.01% | 745 |
|
|
2025
Q2 | $1.39M | Sell |
30,000
-439,700
| -94% | -$21.6M | ﹤0.01% | 986 |
|
|
2025
Q1 | $28.6M | Buy |
469,700
+290,100
| +162% | +$16.9M | 0.08% | 210 |
|
|
2024
Q4 | $10.2M | Sell |
179,600
-34,200
| -16% | -$1.91M | 0.02% | 567 |
|
|
2024
Q3 | $11.1M | Buy |
213,800
+120,400
| +129% | +$5.65M | 0.02% | 520 |
|
|
2024
Q2 | $3.88M | Sell |
93,400
-647,900
| -87% | -$29M | 0.01% | 812 |
|
|
2024
Q1 | $40.2M | Sell |
741,300
-625,600
| -46% | -$31.9M | 0.09% | 187 |
|
|
2023
Q4 | $70.1M | Buy |
1,366,900
+376,200
| +38% | +$19.7M | 0.14% | 132 |
|
|
2023
Q3 | $57.5M | Buy |
990,700
+673,500
| +212% | +$41.3M | 0.13% | 136 |
|
|
2023
Q2 | $20.3M | Sell |
317,200
-973,100
| -75% | -$65.3M | 0.04% | 339 |
|
|
2023
Q1 | $89.4M | Sell |
1,290,300
-3,092,800
| -71% | -$218M | 0.18% | 93 |
|
|
2022
Q4 | $315M | Buy |
4,383,100
+2,172,600
| +98% | +$164M | 0.49% | 27 |
|
|
2022
Q3 | $157M | Sell |
2,210,500
-416,800
| -16% | -$30.2M | 0.24% | 61 |
|
|
2022
Q2 | $202M | Buy |
2,627,300
+1,207,900
| +85% | +$92M | 0.19% | 81 |
|
|
2022
Q1 | $104M | Buy |
+1,419,400
| New | +$95.3M | 0.05% | 127 |
|
|
2020
Q4 | – | Sell |
-1,709,200
| Closed | -$103M | – | 2476 |
|
|
2020
Q3 | $103M | Buy |
1,709,200
+195,100
| +13% | +$11.7M | 0.08% | 222 |
|
|
2020
Q2 | $89M | Sell |
1,514,100
-167,400
| -10% | -$10M | 0.1% | 154 |
|
|
2020
Q1 | $93.7M | Buy |
1,681,500
+438,300
| +35% | +$26.8M | 0.12% | 120 |
|
|
2019
Q4 | $79.8M | Buy |
1,243,200
+31,100
| +3% | +$1.78M | 0.09% | 156 |
|
|
2019
Q3 | $61.5M | Buy |
1,212,100
+828,100
| +216% | +$38.9M | 0.07% | 158 |
|
|
2019
Q2 | $17.4M | Sell |
384,000
-956,700
| -71% | -$44.6M | 0.02% | 391 |
|
|
2019
Q1 | $64M | Buy |
1,340,700
+1,038,500
| +344% | +$51.7M | 0.07% | 130 |
|
|
2018
Q4 | $15.7M | Buy |
302,200
+210,200
| +228% | +$11.3M | 0.02% | 398 |
|
|
2018
Q3 | $5.71M | Sell |
92,000
-68,000
| -43% | -$4.04M | 0.01% | 665 |
|
|
2018
Q2 | $8.86M | Sell |
160,000
-664,700
| -81% | -$35.9M | 0.01% | 461 |
|
|
2018
Q1 | $52.2M | Buy |
824,700
+349,700
| +74% | +$22.5M | 0.07% | 131 |
|
|
2017
Q4 | $29.1M | Buy |
475,000
+325,000
| +217% | +$20.3M | 0.04% | 203 |
|
|
2017
Q3 | $9.56M | Buy |
+150,000
| New | +$8.76M | 0.02% | 413 |
|
|
2017
Q2 | – | Sell |
-152,200
| Closed | -$8.28M | – | 2319 |
|
|
2017
Q1 | $8.28M | Sell |
152,200
-267,900
| -64% | -$14.7M | 0.02% | 430 |
|
|
2016
Q4 | $24.6M | Buy |
420,100
+198,100
| +89% | +$10.8M | 0.05% | 239 |
|
|
2016
Q3 | $12M | Buy |
222,000
+196,500
| +771% | +$12.6M | 0.02% | 384 |
|
|
2016
Q2 | $1.88M | Sell |
25,500
-65,000
| -72% | -$4.59M | ﹤0.01% | 950 |
|
|
2016
Q1 | $5.78M | Buy |
90,500
+55,300
| +157% | +$3.49M | 0.01% | 531 |
|
|
2015
Q4 | $2.42M | Sell |
35,200
-229,800
| -87% | -$15.2M | ﹤0.01% | 949 |
|
|
2015
Q3 | $15.7M | Buy |
265,000
+132,900
| +101% | +$8.43M | 0.03% | 308 |
|
|
2015
Q2 | $8.79M | Sell |
132,100
-157,900
| -54% | -$10.4M | 0.02% | 523 |
|
|
2015
Q1 | $18.7M | Buy |
290,000
+270,000
| +1,350% | +$16.9M | 0.04% | 326 |
|
|
2014
Q4 | $1.18M | Sell |
20,000
-478,100
| -96% | -$27M | ﹤0.01% | 1391 |
|
|
2014
Q3 | $25.5M | Sell |
498,100
-310,700
| -38% | -$15.5M | 0.08% | 216 |
|
|
2014
Q2 | $39.2M | Buy |
808,800
+758,800
| +1,518% | +$37.4M | 0.16% | 94 |
|
|
2014
Q1 | $2.6M | Sell |
50,000
-341,000
| -87% | -$18.1M | 0.02% | 528 |
|
|
2013
Q4 | $20.8M | Buy |
391,000
+207,600
| +113% | +$10.6M | 0.1% | 180 |
|
|
2013
Q3 | $8.49M | Sell |
183,400
-85,400
| -32% | -$3.75M | 0.04% | 284 |
|
|
2013
Q2 | $12M | Buy |
+268,800
| New | +$11.7M | 0.06% | 247 |
|
Other funds holding BMY
VCM
VPM
Parallax Volatility Advisers's BMY Position: Q1 2026 in Review
Parallax Volatility Advisers opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 30,431 shares worth $1.81M. The stake represents ﹤0.01% of the portfolio and ranks #813 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in BMY as recently as Q2 2025.
Parallax Volatility Advisers first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $95M in Q1 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Parallax Volatility Advisers held 30,431 shares of Bristol-Myers Squibb worth $1.81M as of Q1 2026.
- Bristol-Myers Squibb was a new Parallax Volatility Advisers position in Q1 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #813 holding.
- Parallax Volatility Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
- Parallax Volatility Advisers's Bristol-Myers Squibb position peaked at $95M in Q1 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.